Driving Coronary Artery Disease Market Growth in 2025: The Role of The Influence Of Rising Coronary Artery Disease Prevalence Fuels The Coronary Artery Disease Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Coronary Artery Disease Market Size Growth Forecast: What to Expect by 2025?
The market size for coronary artery disease has seen a significant expansion in the past years. A rise from $29.15 billion in 2024, to an estimated $31.97 billion in 2025 at a compound annual growth rate (CAGR) of 9.7% is projected. Factors such as the common incidence of coronary artery disease, an upward trend in minimally invasive surgeries, a growing trend of inactive lifestyles, an aging population and prevalence of CAD, in addition to advancements in pharmacological treatments can explain the growth observed during the historical period.

How Will the Coronary Artery Disease Market Size Evolve and Grow by 2029?
The market size for coronary artery disease is predicted to experience significant expansion in the upcoming years, reaching $48.48 billion in 2029 with an annual growth rate of 11.0%. The projected growth during this period is due to factors such as lifestyle changes, an emphasis on telemedicine and long-distance monitoring, broadening of interventional cardiology procedures, a shift towards value-oriented healthcare frameworks, and the introduction of new drug treatments. The period is also expected to witness notable trends including development of genetic therapies, application of artificial intelligence in diagnosis, an increased focus on mental health within CAD care, an upswing in home-based healthcare services, and an uptake of remote cardiac rehabilitation.

View the full report here:
https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report

What Drivers Are Propelling the Growth of Coronary Artery Disease Market Forward?
The growth of the coronary artery disease market is anticipated to be fuelled by an increase in the number of coronary artery disease cases over the forthcoming years. Characterized by a blockage or narrowing of the arteries supplying blood to the heart, coronary artery disease (CAD) is a health issue that's been surging due to factors like modifications in diet, stress, insufficient exercise, obesity, and aging among others. Treatment for this disease often involves medications such as clopidogrel, ticagrelor, warfarin, and heparin or procedures including coronary artery bypass grafting, angioplasty, and stenting. The Centre of Disease Control and Prevention stated in May 2023 that coronary heart disease (CHD) was the major type of heart disease, causing 371,506 deaths in 2022 in the U.S. About 5% of adults over the age of 20 (1 in 20) had coronary artery disease (CAD). In 2022, approximately one fifth of cardiovascular disease (CVD) fatalities involved individuals below 65 years of age. Thus, the rising occurrence of coronary artery disease is predicted to stimulate the coronary artery disease market throughout the forecasted period.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12052&type=smp

Which Emerging Trends Are Transforming the Coronary Artery Disease Market in 2025?
Leading corporations within the coronary artery disease market are intent on leveraging advanced technologies like AI-based blood tests to strengthen their competitive position. An AI-based blood test is a diagnostic tool that uses Artificial Intelligence algorithms to analyze and interpret data related to blood. For instance, Cardio Diagnostics Holdings, an American AI-based integrated genetic-epigenetic engine manufacturer, launched PrecisionCHD in February 2023. This combined genetic and epigenetic blood test is specifically designed for early coronary heart disease detection. With over 75% sensitivity in detecting coronary heart disease in both genders, PrecisionCHD adopts a machine-learning model gathered from the analysis of genomic and epigenomic data points in the billions. This includes epigenetic (DNA methylation) and genetic (single nucleotide polymorphism) biomarkers.

What Are the Key Segments in the Coronary Artery Disease Market?
The coronary artery disease market covered in this report is segmented -

1) By Treatment: Medication, Surgery, Additional Therapy, Other Treatments
2) By Diagnosis: Electrocardiogram, Echocardiogram, Stress Test, Cardiac Catheterization, Heart CT Scan, Other Diagnosis
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Channels
4) By End-User: Hospitals, Specialty Clinics, Other End-Users

Subsegments:
1) By Medication: Antiplatelet Agents, Beta-Blockers, Statins, ACE Inhibitors, Other Medications
2) By Surgery: Coronary Artery Bypass Grafting, Angioplasty And Stenting, Heart Valve Surgery, Other Surgical Interventions
3) By Additional Therapy: Cardiac Rehabilitation, Lifestyle Modification Programs, Alternative Therapies
4) By Other Treatments: Gene Therapy, Stem Cell Therapy, Innovative Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12052&type=smp

Who Are the Key Players Shaping the Coronary Artery Disease Market's Competitive Landscape?
Major companies operating in the coronary artery disease market include Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Gilead Sciences Inc., Amgen Inc. , Viatris Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Chiesi Farmaceutici S.p.A., Lupin Pharmaceuticals Inc., Wockhardt Ltd., Honya Medical Inc., Idorsia Pharmaceuticals Ltd., Cytokinetics Inc., Kowa Pharmaceuticals America Inc., Sinotau Pharmaceutical Group, HRV Global Life Sciences, Barr Pharmaceuticals Inc., AdvanceCor GmbH, Deutsches Zentrum für Herz- Kreislauf-Forschung (DZHK) e.V.

What Geographic Markets Are Powering Growth in the Coronary Artery Disease Market?
North America was the largest region in the coronary artery disease market in 2024. The regions covered in the coronary artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12052

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.